- ►diabetesjournals.org S Schwartz, V Fonseca, B Berner, M Cramer, … - Diabetes Care, 2006 - Am Diabetes Assoc RESULTS—Significant decreases (P < 0.001) in mean HbA 1c (A1C) levels were
observed by week 12 in all treatment groups. The mean changes from baseline to
end point in the two groups given 1,500 mg extended-release metformin ... Cited by 27 - Related articles - BL Direct - All 10 versions
SL Schwartz, JF Wu, B Berner - Expert Opin. Pharmacother., 2006 - informahealthcare.com Metformin extended release (ER) (Glumetza™, Depomed, Inc.) is a recently
approved formulation that provides effective and well-tolerated glycaemic
control with once-daily dosing. Metformin ER has similar bioavailability to ... Cited by 6 - Related articles - BL Direct - All 6 versions
K Fujioka, RL Brazg, I Raz, S Bruce, S Joyal, … - Diabetes Obesity and Metabolism, 2005 - interscience.wiley.com Methods: In Protocol 1, 240 patients were randomized to receive metformin XR
1000 mg once daily. or placebo in a 2 : 1 ratio for 12 weeks (patients could
receive metformin XR 1500 mg during weeks 12–24 if required). In Protocol ... Cited by 23 - Related articles - All 3 versions
SYE Hou, VE Cowles, B Berner - Critical reviews in therapeutic drug carrier systems, 2003 - cat.inist.fr Gastric retentive dosage forms have been investigated to provide controlled
release therapy for drugs with reduced absorption in the lower
gastrointestinal(GI) tract or for local treatment of diseases of the ... Cited by 31 - Related articles - BL Direct - All 6 versions
- ►adisonline.com [PDF] P Timmins, S Donahue, J Meeker, P Marathe - Clinical pharmacokinetics, 2005 - ingentaconnect.com 0312-5963/05/0007-0721/$34.95/0 2005 Adis Data Information BV. All rights
reserved. ... Peter Timmins, 1 Steve Donahue, 2 Jeff Meeker 2 and Punit Marathe
2 ... 1 Bristol-Myers Squibb Company, Pharmaceutical Research Institute, ... Cited by 11 - Related articles - All 7 versions
G Gusler, J Gorsline, G Levy, SZ Zhang, IE … - The Journal of Clinical Pharmacology, 2001 - jcp.sagepub.com M etformin hydrochloride, an antidiabetic drug, which became commercially
available in 1959 andintheUnitedStatesin1995,lowersbothbasal-and
postprandial-elevated blood glucose in patients with non-insulin-dependent ... Cited by 44 - Related articles - BL Direct - All 6 versions
B Berner, VE Cowles - Expert Opin. Drug Deliv., 2006 - Informa Pharma Science Swelling tablets administered in the fed state have been shown to provide
therapeutic advantages in two marketed products, with the duration of delivery
characterised with respect to food and tablet size. Metformin ... Cited by 4 - Related articles - BL Direct - All 5 versions
CB Washington, SYE Hou, C Campanella, N … - The Journal of Clinical Pharmacology, 2005 - jclinpharm.highwire.org Two open-label, randomized, 2-way crossover studies (1 single-dose and 1
steady-state) were conducted in healthy volunteers to compare the
pharmacokinetics and pharmacodynamics of a novel extended-release ... Cited by 6 - Related articles - BL Direct - All 5 versions
- ►nih.gov JL Fourcroy, B Berner, YK Chiang, M Cramer, … - Antimicrobial agents and chemotherapy, 2005 - aac.highwire.org The efficacy and safety of a novel once-daily extended-release ciprofloxacin
(ciprofloxacin ER) 500-mg dose were compared with those of an immediate-release
ciprofloxacin (ciprofloxacin IR) 250-mg twice-daily dose, each administered ... Cited by 8 - Related articles - BL Direct - All 11 versions
